To manage the development and progression of glaucoma, researchers at Stanford University have developed a biocompatible suprachoroidal spacer implant.
A Stanford researcher has designed an artificial lens capsule as a drug delivery device inserted at the time of cataract surgery, to address issues of extended drug delivery to the eye with minimal complications.